Home   Business   Life Science

Life Science




AstraZeneca announces positive results for phase III trial of Lynparza in advanced ovarian cancer

AstraZeneca announces positive results for phase III trial of Lynparza in advanced ovarian cancer

AstraZeneca announces positive results for phase III trial of Lynparza in advanced ovarian cancer

It showed potential benefit of adding drug to standard treatment


Encouraging phase III trial results for AstraZeneca for lung cancer and prostate cancer drugs

Encouraging phase III trial results for AstraZeneca for lung cancer and prostate cancer drugs

Encouraging phase III trial results for AstraZeneca for lung cancer and prostate cancer drugs

Positive findings for Tagrisso and Lynparza


Lonza latest pharma for Chesterford Research Park

Lonza latest pharma for Chesterford Research Park

Lonza latest pharma for Chesterford Research Park

Swiss multinational provides contract development and manufacturing services to the pharmaceutical and biotech industries


Rowena Gardner appointed to board at One Nucleus

Rowena Gardner appointed to board at One Nucleus

Rowena Gardner appointed to board at One Nucleus

The not-for-profit membership organisation champions the life sciences cluster in the East of England and London


Government backing for Optibrium leads to two Asia contracts

Government backing for Optibrium leads to two Asia contracts

Government backing for Optibrium leads to two Asia contracts

Small molecule design team secure business in China and Japan with support from Department of International Trade


AstraZeneca sales rise 12% - and busy second half of 2019 predicted

AstraZeneca sales rise 12% - and busy second half of 2019 predicted

AstraZeneca sales rise 12% - and busy second half of 2019 predicted

Results in China are strong and European market returns to growth too


Takeda takes out second licence on Crescendo Biologics’ Humabody therapeutics

Takeda takes out second licence on Crescendo Biologics’ Humabody therapeutics

Takeda takes out second licence on Crescendo Biologics’ Humabody therapeutics

Decision represents further success in oncology collaboration for Babraham Research Campus company


eLife unveils demo of open-source research journal publishing system

eLife unveils demo of open-source research journal publishing system

eLife unveils demo of open-source research journal publishing system

Non-profit organisation aims to provide free end-to-end solution for scholarly publishing


Founders of Astex Pharmaceuticals recalls its beginnings at 20th anniversary party

Founders of Astex Pharmaceuticals recalls its beginnings at 20th anniversary party

Founders of Astex Pharmaceuticals recalls its beginnings at 20th anniversary party

The Cambridge Science Park company holds garden party at Longstowe Hall


How medical research is aided by 140,000 volunteers in the NIHR BioResource

How medical research is aided by 140,000 volunteers in the NIHR BioResource

How medical research is aided by 140,000 volunteers in the NIHR BioResource

It started in Cambridge and is now key to many scientific studies


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More